📰 Daventry Group News
Daventry Group News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Daventry Group. Real-time updates on events, politics, business and more.
February 8, 2024
Health care advisory firm Marwood Group renews 19,000 square feet at 733 Third Avenue.
December 28, 2023
North Growth Management Ltd. lifted its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 15.6% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 37,000 shares of the medical research company’s stock after purchasing an additional 5,000 shares during the […]
November 23, 2023
Health Catalyst, Inc. (NASDAQ:HCAT – Get Free Report) has earned an average rating of “Moderate Buy” from the ten research firms that are covering the stock, Marketbeat reports. Five research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average twelve-month target price among […]
October 31, 2023
Cornerstone Investment Partners LLC bought a new position in shares of Health Catalyst, Inc. (NASDAQ:HCAT – Free Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 13,552 shares of the company’s stock, valued at approximately $169,000. Other institutional investors also recently bought and […]
September 18, 2023
Cantor Fitzgerald reaffirmed their overweight rating on shares of Health Catalyst (NASDAQ:HCAT – Free Report) in a research note issued to investors on Thursday, Benzinga reports. The firm currently has a $16.00 target price on the stock. Separately, Canaccord Genuity Group reduced their price target on shares of Health Catalyst from $16.00 to $14.00 and […]
September 9, 2023
Shares of Health Catalyst, Inc. (NASDAQ:HCAT – Get Free Report) have received an average recommendation of “Moderate Buy” from the twelve research firms that are covering the stock, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average […]
September 4, 2023
Daventry Group LP acquired a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 63,123 shares of the medical research company’s stock, valued at approximately $12,739,000. Charles […]
September 4, 2023
Daventry Group LP raised its position in New Relic, Inc. (NYSE:NEWR – Free Report) by 11.3% in the 1st quarter, Holdings Channel reports. The fund owned 285,646 shares of the software maker’s stock after acquiring an additional 28,919 shares during the period. New Relic accounts for approximately 15.0% of Daventry Group LP’s holdings, making the […]
September 4, 2023
Daventry Group LP increased its holdings in shares of Everbridge, Inc. (NASDAQ:EVBG – Free Report) by 23.8% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 558,678 shares of the technology company’s stock after buying an additional 107,530 shares during the quarter. […]
July 21, 2023
Health Catalyst, Inc. (NASDAQ:HCAT – Get Free Report) saw a large drop in short interest during the month of June. As of June 30th, there was short interest totalling 1,210,000 shares, a drop of 12.9% from the June 15th total of 1,390,000 shares. Based on an average daily volume of 451,000 shares, the days-to-cover ratio […]